Conducting an Initial, Small, Controlled Clinical Trial to Assess for Licorice Combination Separate Dietary Supplements Oral Activity That Suggests the Potential for Clinical Benefits of COVID-19 Patients.~20 Lower Than Mild COVID-19 Patients~Positive testing COVID-19 by standard RT-PCR assay~COVID-19 infection without symptoms~Symptoms of mild illness with COVID-19 that could include fever, cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, and loss of taste or smell, without shortness of breath or dyspnea~No clinical signs indicative of Moderate, Severe, or Critical Severity~Our trial duration will be 4-week duration.~Licorice Combination Separate Dietary Supplements Oral~Our trial duration will be 4-week duration~Negative testing COVID-19 by standard RT-PCR assay after oral 10 days
Conducting an Initial, Small, Controlled Clinical Trial to Assess for Licorice Combination Separate Dietary Supplements Oral Activity That Suggests the Potential for Clinical Benefits of COVID-19 Patients.~Treat Infection of Multiple Gene Mutation COVID-19 Virus Strains to target ACE2.